These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20852412)

  • 21. Routine use of Xeomin in patients previously treated with Botox: long term results.
    Dressler D
    Eur J Neurol; 2009 Dec; 16 Suppl 2():2-5. PubMed ID: 20002739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Office-based botulinum toxin injections.
    Shah MD; Johns MM
    Otolaryngol Clin North Am; 2013 Feb; 46(1):53-61. PubMed ID: 23177405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin for treatment of dystonia.
    Dressler D
    Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of botulinum toxin in the neurology clinic.
    Lim EC; Seet RC
    Nat Rev Neurol; 2010 Nov; 6(11):624-36. PubMed ID: 21045798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
    Leippold T; Reitz A; Schurch B
    Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
    Blitzer A; Binder WJ; Aviv JE; Keen MS; Brin MF
    Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):389-92. PubMed ID: 9109785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xeomin: an innovative new botulinum toxin type A.
    Frevert J
    Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin: does the black box warning justify change in practice?
    Narayanan UG
    Dev Med Child Neurol; 2011 Feb; 53(2):101-2. PubMed ID: 21244406
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Madarosis and facial alopecia presumed secondary to botulinum a toxin injections.
    Kowing D
    Optom Vis Sci; 2005 Jul; 82(7):579-82. PubMed ID: 16044070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
    Nijmeijer SW; Koelman JH; Kamphuis DJ; Tijssen MA
    Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin in cervical dystonia.
    Tsui JK; Calne DB
    Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin for spastic GI disorders: a systematic review.
    Zhao X; Pasricha PJ
    Gastrointest Endosc; 2003 Feb; 57(2):219-35. PubMed ID: 12556788
    [No Abstract]   [Full Text] [Related]  

  • 39. Distant effects of local injection of botulinum toxin.
    Lange DJ; Brin MF; Warner CL; Fahn S; Lovelace RE
    Muscle Nerve; 1987; 10(6):552-5. PubMed ID: 3455658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.